Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational survey

• Prif Awduron: Isabelle Arnet (Awdur), Melina Verbeek (Awdur), Birna Almarsdóttir Anna (Awdur), Liese Barbier (Awdur), Rhonda Clifford (Awdur), Christiane Eickhoff (Awdur), Kurt Hersberger (Awdur), Isabelle Huys (Awdur), Kenny Lee (Awdur), Kritsanee Saramunee (Awdur), Martin Schulz (Awdur), David Zgarrick (Awdur), Kati Sarnola (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2021-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and suppor...